IONESCU, M-A., TATU A.T., BUSILA, C., AXENTE A.R., BADALATO, N., FEUILLOLEY, M.G.J., ASQUIER, E., MARTINEZ, J.D., LEFEUVRE, L. Microbiome modulation in acne patients and clinical correlations. Life (2024) 14: 688, 2024; https://doi.org/10.3390/life14060688 (IF2024 =3.2)

FEUILLOLEY, M.G.J., HADJIEV, E., AMEGNONA, L.J.  Interaction of skin-born mediators with the cutaneous microbiota and beyond. Curr. Opin. Endocr. Metab. Res. (2024) 37:100545, 2024; https://doi.org/10.1016/j.coemr.2024.100545 (IF2024 = 1.9)

ZOMMITI, M., FEUILLOLEY M.G.J. Sex hormones – Gut microbiome axis: An update of what is known so far. Curr. Opin. Endocr. Metab. Res. 38: 100571, 2025; (IF2024 = 1.9)

LEBONVALLET, N., CATOVIC, C., FEUILLOLEY M.G., LESCHIERA, R., REUX, A., TALAGAS, M., COUSIN, I., MISERY, L., SIMON, E., CHOPIN, S., GARDÈRES, J. In vitro and in vivo efficacity of the Active Oligo Skin complexTM, a new active ingredient processed from sea water, on multiple parameters of atopic skins. Skin Health Disease 5: 22-30, 2025; doi: 10.1093/skinhd/vzae029 (IF2023 = 1.7)

FEUILLOLEY M.G.J., LESOUHAITIER O. Endocrine Microbiology: A transdisciplinary approach of the human physiology. Curr. Opin. Endocr. Metab. Res. 38: 100570, 2025;  https://doi.org/10.1016/j.coemr.2025.100570 (IF2024 = 1.9)